Controlled release azelastine-containing pharmaceutical compositions
作者： Helmut Hettche
DOI:
关键词: Azelastine 、 Controlled release 、 Chromatography 、 Pharmacology 、 Chemistry
摘要: Azelastine-containing pharmaceutical compositions which provide controlled release of the active substance using a sustained component. The contain azelastine or physiologically acceptable salt azelastine, together with 0.001 to 800 parts component for each part by weight (calculated as base) and rate is between 0.05 5 mg per hour.
lens.org 参考文章(5)
Daniel A. Alderman, Sustained release compositions comprising hydroxypropyl cellulose ethers ,(1985)
Katsu Nakamori, Ikuo Koyama, Tooru Maki, Yasuji Takashima, Method of preparing sustained-release pharmaceutical preparation ,(1986)
Abraham Sunshine, Eugene M. Laska, Carole E. Siegel, Cough/cold mixtures comprising non-sedating antihistamine drugs ,(1988)
Gerhard Scheffler, Jurgen Engel, N-benzyl, phenethyl, methoxyethyl or allyl substituted benzylphthalazinones having antiallergic and antihistamine action ,(1985)
Wolfgang Morick, Gerhard Scheffler, Ilona Fleischhauer, Reinhard Muckenschnabel, Helmut Hettche, Method of treating inflammatory disorders and psoriasis with salts of azelastine ,(1991)